Medtronic Emphasizes International Growth Opportunities
This article was originally published in PharmAsia News
Executive Summary
Medtronic Inc. is betting on emerging markets and the “value” market to be its major growth drivers over the next few years.
You may also be interested in...
Boston Scientific Continues Worldwide Restructuring, Plans Job Cuts
The cuts expand on a 2011 restructuring plan, with hopes of reducing operating expenses by up to $375 million at the end of 2013.
Medtronic Ups Stake In China Cardiac Market With LifeTech Investment
The $66 million deal gives Medtronic a significant stake in LifeTech, a Chinese developer of minimally invasive devices, including balloon catheters, delivery systems, occluders and stent graft systems.
Challenges With ICD Leads Are Under Control, St. Jude Tells Investors
The company was prepared for FDA’s recent warning letter, executives said on an earnings call. But the scrutiny is not over, analysts suggest.